Colecchia, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.778
AS - Asia 2.198
EU - Europa 1.946
SA - Sud America 56
OC - Oceania 16
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 6
Totale 9.015
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.770
SG - Singapore 720
HK - Hong Kong 692
CN - Cina 631
IT - Italia 540
SE - Svezia 500
GB - Regno Unito 271
BG - Bulgaria 202
DE - Germania 123
FI - Finlandia 99
BR - Brasile 50
ID - Indonesia 49
IE - Irlanda 45
LT - Lituania 29
IR - Iran 25
TR - Turchia 21
UA - Ucraina 21
RO - Romania 20
FR - Francia 16
NL - Olanda 16
IN - India 14
AU - Australia 13
VN - Vietnam 11
BE - Belgio 10
CZ - Repubblica Ceca 9
JP - Giappone 9
PK - Pakistan 8
RU - Federazione Russa 8
MK - Macedonia 7
EG - Egitto 6
ES - Italia 6
EU - Europa 6
KR - Corea 6
PL - Polonia 6
TN - Tunisia 6
AT - Austria 5
CA - Canada 5
CL - Cile 5
MY - Malesia 4
MX - Messico 3
NZ - Nuova Zelanda 3
PH - Filippine 3
GR - Grecia 2
HR - Croazia 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
GE - Georgia 1
HU - Ungheria 1
IQ - Iraq 1
JO - Giordania 1
LU - Lussemburgo 1
MA - Marocco 1
TH - Thailandia 1
Totale 9.015
Salva come PNG Salva come JPEG
Città #
Santa Clara 898
Hong Kong 685
Fairfield 645
Singapore 610
Nyköping 472
Chandler 331
Ashburn 265
Wilmington 248
Princeton 238
Woodbridge 231
San Diego 225
Cambridge 203
Sofia 202
Houston 199
Beijing 187
Seattle 143
New York 111
Helsinki 83
London 77
Buffalo 61
Modena 57
Southend 57
Ann Arbor 55
Bologna 49
Jakarta 46
Milan 43
Dublin 42
Rome 40
São Paulo 40
Bremen 37
Shanghai 34
Jacksonville 33
Kilburn 29
Norwalk 27
Guangzhou 23
Reggio Emilia 22
Dearborn 21
Mashhad 18
Munich 14
Prescot 14
Hounslow 13
Chiswick 11
Florence 11
Palermo 11
Timisoara 11
Izmir 10
Lappeenranta 10
Parma 10
Amsterdam 9
Brno 9
Brussels 9
Council Bluffs 9
Chicago 8
Rimini 8
Eugene 7
Southwark 7
Turin 7
Wuhan 7
Acton 6
Bari 6
Carpi 6
Des Moines 6
Tanta 6
Frankfurt am Main 5
Hangzhou 5
Hanover 5
Padova 5
Redwood City 5
San Mateo 5
Vienna 5
Vitória 5
Wandsworth 5
Augusta 4
Catania 4
Cesena 4
Cluj-Napoca 4
Dallas 4
Hanoi 4
Ho Chi Minh City 4
Iasi 4
Istanbul 4
Jinhua 4
Leeds 4
Manchester 4
North Kansas City 4
Paris 4
Sydney 4
Washington 4
Adelaide 3
Assago 3
Brescia 3
Casteldaccia 3
Chengdu 3
Legnaro 3
Los Angeles 3
Megrine 3
Melbourne 3
Naples 3
Pavia 3
Perugia 3
Totale 7.157
Salva come PNG Salva come JPEG
Nome #
Gut Microbiota and Celiac Disease. 211
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 171
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 169
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure. 163
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 159
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 124
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 90
Growth and nutritional evaluation in children with chronic liver disease (CLD) before and after liver transplantation 88
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 85
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 83
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 83
Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL) 78
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 78
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 74
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 71
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 66
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 65
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study 64
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 64
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 64
Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease 63
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load 63
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma 61
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 60
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 60
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 60
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 58
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 58
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 58
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness 57
Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease 57
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 56
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 56
"Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?" 56
Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature 56
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 56
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 54
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 54
Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients 53
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma 53
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 53
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years 52
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 52
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 51
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 50
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 50
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 50
Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice 49
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 47
Hepatic steatosis in obese patients: clinical aspects and prognostic significance 47
Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods 47
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 47
Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study 46
Diverticular disease of the colon: new perspectives in symptom development and treatment 46
Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance 46
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 46
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 45
IMPULSIONAL, POINT AND BIDIMENSIONAL SHEAR WAVE ELASTOMETRY FOR PORTAL HYPERTENSION: SAME STIFFNESS THRESHOLDS? 45
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 45
Gut microbiota and metabolic syndrome 45
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 45
Bacteria flora,gas and antibiotics 43
Autoimmune liver diseases in a paediatric population with coeliac disease. A 10-year single-centre experience 43
Are noninvasive methods clinically useful in advanced, decompensated liver cirrhosis when "les Jeux Sont Faits"? 42
Dysbiosis in Celiac disease patients with persistent symptoms on gluten-free diet: a condition similar to that present in irritable bowel syndrome patients? 42
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 42
Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well) 41
Prognostic Value of the Albumin-Bilirubin Grade for the Prediction of Post-Hepatectomy Liver Failure: A Systematic Review and Meta-Analysis. 41
Primary biliary cholangitis-primary sclerosing cholangitis in an evolving overlap syndrome: A case report 41
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 41
Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: results of an open, controlled trial 41
Post COVID-19 irritable bowel syndrome 40
A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease 40
The role of liver and spleen elastography in advanced chronic liver disease 40
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 39
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 39
A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study 39
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness. 39
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 38
Fish oil based emulsion for the treatment of parenteral nutrition associated liver disease in adult patient 38
Transient Elastography (FibroScan) Is Not Correlated With Liver Fibrosis but With Cholestasis in Patients With Long-Term Home Parenteral Nutrition 38
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 38
Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives 38
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations 38
Benign hepatic nodular lesions after treatment for childhood cancer 38
Italian consensus conference for colonic diverticulosis and diverticular disease 38
Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study 37
Body weight,lifestyle,dietary habits and gastroesophageal reflux disease 37
Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels 37
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 37
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 37
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 36
Non-invasive tests for the prediction of primary hepatocellular carcinoma 36
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 36
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 36
Imaging Software-Based Sarcopenia Assessment in Gastroenterology: Evolution and Clinical Meaning 36
Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence 36
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation 36
Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome 35
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 35
Totale 5.707
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.437
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020183 0 0 0 0 25 42 36 29 21 7 16 7
2020/2021306 14 6 15 17 14 21 16 28 76 27 60 12
2021/20222.566 35 27 12 8 34 29 743 185 338 48 754 353
2022/20231.813 307 184 151 85 162 208 46 249 211 30 87 93
2023/20242.351 30 91 133 139 469 157 129 220 364 140 130 349
2024/20251.785 141 33 55 540 1.016 0 0 0 0 0 0 0
Totale 9.289